Form D · Other Health Care

WellDoc, Inc.

Baltimore, MD · CIK 0001459113

Offering snapshot reported Apr 4, 2016 · SEC filing

Reported sold
$29.1M
Offering amount: $31.6M
Investors reported
58
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 16, 2015
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$14.5M$29.1MDec 23, 2015: $22,024,949.00Dec 23, 2015Apr 4, 2016: $29,074,404.00Apr 4, 2016

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$22,024,949 → $29,074,404
  • Reported investors44 → 58

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 4, 2016Amendment$29,074,404$7,049,455vs Dec 23, 201558SEC filing
Dec 23, 2015Initial$22,024,949No comparison44SEC filing
Jul 30, 2015Initial$225,000No comparison3SEC filing
Mar 10, 2015Amendment$4,546,650$316,588vs Feb 23, 201530SEC filing
Feb 23, 2015Amendment$4,230,062$4,080,062vs Dec 9, 201425SEC filing
Dec 9, 2014Initial$150,000No comparison1SEC filing
Jan 9, 2014Amendment$15,736,399$15,536,399vs Dec 9, 201313SEC filing
Dec 20, 2013Initial$150,000No comparison1SEC filing
Dec 20, 2013Initial$1,000,000No comparison1SEC filing
Dec 20, 2013Initial$1,000,000No comparison1SEC filing
Dec 9, 2013Initial$200,000No comparison2SEC filing
Oct 21, 2013Amendment$8,389,995$7,881,395vs Aug 15, 20129SEC filing
Aug 15, 2012Initial$508,600No comparison6SEC filing
Aug 1, 2011InitialYet to sellNo comparison0SEC filing
Mar 20, 2009Initial$196,965No comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$1.25M
Finders' fees
$0
Form D file number
021-253721
Includes cash proceeds of $15,949,997.20, conversion of debt and issuance of equity pursuant to certain Agreements for Future Equity.
Amount consisted of a $900,000 cash payment and issuance of shares of Series B Stock in the amount of $350,000.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Cowen and Company7616

Source: Form D, filed Apr 4, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Don Almeida Director
Donald V. Almeida Director
Jen Beachell Executive
Chris Bergstrom Executive
Jon Brilliant Director, Executive
Suzanne Clough Executive
Suzanne Clough, Md Executive
Juan Enriquez Director
Michael I. Greenbaum Director
Stewart Greenebaum Director
Michael Greenebaum Director
Brandon Gretz Executive
John Hawks Director
Anand Iyer Executive
Anand K. Iyer, Ph.D Executive
Maxwell Kahn Director
David Levy Director
Terry Lierman Director
Kevin Mc Raith Director, Executive
David I. Stevenson Director
Hyuk Jeen Suh Director
Ryan Sysko Director, Executive
Gene Van Slyke Executive
Caroline York Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
1501 St. Paul Street Suite 118
Baltimore, MD, 21202